查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2018808

心臟假体市场：2026年至2032年全球市场预测（依产品类型、手术、材料类型、适应症和最终用户划分）

Cardiac Prosthetic Devices Market by Product Type, Procedure Approach, Material Type, Indication, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，心臟假体市场价值将达到 115.7 亿美元，到 2026 年将成长至 134.2 亿美元，到 2032 年将达到 332.4 亿美元，复合年增长率为 16.26%。

主要市场统计数据
基准年 2025 115.7亿美元
预计年份：2026年 134.2亿美元
预测年份 2032 332.4亿美元
复合年增长率 (%) 16.26%

权威说明指出，设备设计的创新、临床实践的变化以及不断变化的监管要求正在重新定义心臟假体设备的策略。

心臟假体领域是一个充满活力的领域，它融合了先进的生物医学工程、不断发展的临床实践和不断变化的卫生经济学。过去十年，医疗专业人员和器械製造商不再满足于渐进式改进，而是致力于寻求集机械可靠性、生物相容性材料和手术灵活性于一体的综合解决方案。这种发展反映了临床医生对能够降低手术全期风险、缩短恢復时间并改善日益复杂的患者群体长期功能预后的器械的日益增长的需求。

展望未来，概述了正在重塑心臟假体生态系统的突破性程序创新、材料技术进步和商业性重组。

心臟假体领域正经历一系列变革，这些变革正在重塑竞争优势和临床实践的格局。经导管技术，得益于导管输送系统和影像技术的进步，正在拓展过去需要开胸手术才能完成的适应症，并使高风险患者的治疗成为可能。同时，设备的微型化以及将感测功能和连接功能整合到植入式平台中，使得与远端监测、自适应治疗流程和基于价值的医疗保健模式的更紧密结合成为可能。

对美国贸易措施的变化如何累积重塑整个心臟假体供应链的采购、製造地和临床准入进行详细分析。

近期美国政策调整引发的贸易措施变化，对心臟假体的整个供应链产生了一系列累积影响，涵盖采购、製造到临床应用等各个环节。直接影响之一是某些进口零件成本的增加，迫使设备製造商和经销商重新评估其供应商合约和库存策略。为此，许多机构正在加快供应商多元化、采用双重采购策略，并建立区域库存缓衝，以确保手术安排，降低单一供应来源中断的风险。

全面的细分洞察揭示了产品类型、治疗方法、材料选择、最终用户需求和临床适应症如何相互交织，从而塑造商业性和临床策略。

精细的市场細項分析揭示了临床需求、手术方法选择和材料科学如何相互交织，从而创造出差异化的市场机会。依产品类型分析市场，植入式心臟整流去颤器(ICD) 可细分为双腔、单腔和皮下植入式系统等不同的子类别，每种类别都有其独特的临床应用场景和技术要求。左心室辅助装置 (LVAD) 分为持久型和临时型，反映了目标患者群体和服务模式的差异。心律调节器包括双心室型、双腔型和单腔型，其工作模式和编程复杂程度会影响后续护理和远端监测的需求。人工瓣膜分为生物瓣膜和机械瓣膜，生物瓣膜可进一步细分为同种异体移植瓣膜和异种异质骨移植瓣膜。所有这些都对瓣膜的耐用性、抗凝血治疗管理和医病沟通产生重大影响。

对美洲、欧洲、中东、非洲和亚太地区的地理差异如何影响临床引入、监管方法和商业策略进行策略评估。

区域趋势对心臟假体的研发、核准、部署和支援有显着影响。在美洲，成熟的医保报销体系和众多先进心臟中心推动了对创新经导管解决方案、整合远端监测和长期设备服务项目的需求。该地区的临床领导者通常透过对比研究和参与註册研究来推动循证医学证据的积累，而商业性成功通常取决于牢固的临床关係和全面的护理提案。

这提供了关键的竞争和营运方面的见解，让我们了解设备製造商如何利用研究、伙伴关係和服务模式来确保在人工心臟瓣膜市场的领先地位。

心臟人工瓣膜领域的主要企业正透过创新、服务伙伴关係和生态系统合作相结合的方式，维持并扩大其竞争优势。关键研发领域包括新一代瓣叶技术、低剖面导管系统、用于植入式心律不整管理装置的改良型感测演算法，以及能够简化植入过程并减少装置相关併发症的机械设计。在商业方面，各企业正投资于培训中心、导师网络和长期服务合同，以增强临床忠诚度并创造稳定的售后市场收入。

为医疗器材开发商和医疗保健系统领导者提供可操作且优先考虑的建议，以建立商业化策略，包括强大的供应链、证据计划和支付方合作。

产业领导者应优先考虑多管齐下的方法，以平衡创新、业务永续营运和与支付方的合作。首先，投资于临床证据项目，利用註册登记、疗效比较研究和真实世界数据，证明患者疗效和医疗成本的显着改善，从而为临床医生和支付方构建令人信服的论证。其次，探讨在地化生产和双重采购模式，以加强与供应商的关係，确保医院治疗的连续性，并规避贸易政策波动带来的风险。

清楚地解释多方面的研究途径，该方法结合了对临床医生的访谈、对监管和临床证据的审查以及供应链分析，以确保获得可靠、可操作的见解。

本研究整合了对心臟外科医生、介入性心臟病专家、采购经理和器械工程师的专家访谈所得的第一手资料，并系统回顾了监管申报文件、临床试验註册资讯和同行评审的临床文献。透过交叉检验定量和定性讯息，我们识别了不同产品类型和手术方法的推广应用驱动因素、临床障碍和操作限制。

结论强调，迫切需要协调临床、监管和营运策略，将创新转化为永续的临床部署和市场韧性。

总之，心臟假体领域正处于转折点，临床创新、手术流程变革、材料进步和不断演变的经营模式在此交会融合，势必重塑患者照护路径。那些能够将产品开发与严谨的循证医学证据收集、稳健的生产策略以及与支付方的合作相结合的机构，将能够实现价值最大化，并在各种临床环境中持续获得应用。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 心臟假体市场：依产品类型划分

  • 植入式心臟整流去颤器
    • 双腔去心房颤动
    • 单腔去心房颤动
    • 皮下除颤去心房颤动
  • 左心室辅助装置
    • 耐用型心室辅助装置
    • 暂时性心室辅助装置
  • 起搏器
    • 双心室节律器
    • 双腔起搏器
    • 单腔起搏器
  • 人工瓣膜
    • 生物瓣膜
    • 机械阀

第九章：心臟假体市场：依手术方式划分。

  • 开胸手术
    • 微创手术
    • 传统胸骨切开术
  • 经导管
    • 经导管主动脉瓣置换术
    • 经导管二尖瓣置换术

第十章：心臟假体市场：依材料类型划分

  • 生物瓣膜
    • 同种异体移植
    • 异质骨移植
  • 机械的
    • 二尖瓣
    • 倾斜式碟阀

第十一章：心臟假体市场：依适应症划分

  • 主动脉
    • 回流
    • 收缩
  • 二尖瓣
    • 回流
    • 收缩
  • 肺动脉
  • 三尖瓣

第十二章 心臟假体市场：依最终使用者划分

  • 门诊手术中心
  • 心臟中心
  • 医院

第十三章 心臟假体市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章：心臟假体市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章：心臟假体市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国：心臟假体市场

第十七章 中国：心臟假体市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Artivion, Inc.
  • AtriCure, Inc.
  • Biotronik SE & Co KG
  • Boston Scientific Corporation
  • Braile Biomedica
  • Colibri Heart Valve LLC
  • Edwards Lifesciences Corporation
  • Fortive Corporation
  • Lepu Medical Technology（Beijing）Co.,Ltd.
  • LivaNova, PLC
  • Medtronic PLC
  • Meril Life Sciences Pvt. Ltd.
  • Microport Scientific Corporation
  • SGS Societe Generale de Surveillance SA.
  • Shree Pacetronix Ltd.
  • Siemens Healthineers AG
  • TZ Medical
  • Venus MedTech HangZhou Inc.
  • Vitatron Holding BV
Product Code: MRR-ED54C46E8699

The Cardiac Prosthetic Devices Market was valued at USD 11.57 billion in 2025 and is projected to grow to USD 13.42 billion in 2026, with a CAGR of 16.26%, reaching USD 33.24 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 11.57 billion
Estimated Year [2026] USD 13.42 billion
Forecast Year [2032] USD 33.24 billion
CAGR (%) 16.26%

An authoritative introduction to how innovation in device design, clinical practice shifts, and evolving regulatory expectations are redefining cardiac prosthetic device strategy

The field of cardiac prosthetic devices sits at a dynamic intersection of advanced biomedical engineering, evolving clinical practice, and shifting healthcare economics. Over the last decade practitioners and device makers have moved beyond incremental improvements to pursue integrated solutions that combine mechanical reliability, biocompatible materials, and procedural versatility. This evolution reflects growing clinician demand for devices that reduce perioperative risk, shorten recovery time, and improve long-term functional outcomes for increasingly complex patient cohorts.

Regulatory scrutiny and payer expectations have concurrently heightened, requiring manufacturers to generate robust real-world evidence and demonstrate clear value propositions to hospitals and cardiac centers. Supply chain complexity and component specialization have introduced new procurement and manufacturing considerations, prompting original equipment manufacturers to rethink supplier relationships and vertical capabilities. As a result, strategy discussions among executive teams now routinely consider not only product design but also evidence generation, service models, and lifecycle economics.

Looking ahead, opportunities for differentiation will center on convergent innovations: miniaturized electronics, advanced polymer and tissue solutions, device durability enhancements, and procedural approaches that favor less invasive access. Stakeholders who align clinical evidence plans, regulatory pathways, and commercialization tactics will be best positioned to translate scientific promise into sustained clinical adoption and long-term commercial success.

A forward looking synthesis of radical procedural innovations, materials advances, and commercial realignments that are reshaping the cardiac prosthetic device ecosystem

The cardiac prosthetic landscape is undergoing a set of transformative shifts that are remapping competitive advantage and clinical practice. Transcatheter techniques, propelled by advances in catheter delivery systems and imaging, are expanding indications previously handled via open cardiac surgery and enabling treatment of higher-risk patients. At the same time, device miniaturization and the integration of sensing and connectivity into implantable platforms are enabling remote monitoring, adaptive therapy algorithms, and closer alignment with value-based care models.

Materials science has introduced longer-lasting biological and synthetic options that reduce thrombogenicity and improve hemodynamic performance, while manufacturing innovations such as additive manufacturing and precision machining are enabling more complex geometries and tailored device footprints. Health systems are placing greater emphasis on total cost of care, driving device strategies that emphasize procedural efficiency, reduced length of stay, and lower complication rates. Finally, collaborative models between device companies, clinical centers, and payers are becoming more common, with shared data initiatives and risk-sharing agreements accelerating evidence generation and reimbursement alignment.

These shifts are not uniform across geographies or clinical settings, but together they are raising the bar for entrants and incumbents alike: success will depend on integrating clinical, regulatory, and commercial threads into coherent programs that can demonstrate patient benefit and economic rationale in real-world practice.

An in depth analysis of how evolving United States trade measures are cumulatively reshaping procurement, manufacturing footprints, and clinical access across cardiac prosthetic supply chains

Evolving trade measures originating from recent policy adjustments in the United States have introduced a set of cumulative effects across procurement, manufacturing, and clinical supply chains for cardiac prosthetic devices. The immediate impact has been higher landed costs for certain imported components, prompting device manufacturers and distributors to reassess supplier contracts and inventory strategies. In response, many organizations have accelerated supplier diversification, dual-sourcing strategies, and regional inventory buffers to protect operating room schedules and reduce exposure to single-source disruptions.

Beyond short-term pricing pressure, these trade dynamics are influencing strategic decisions around manufacturing footprint and capital allocation. Some manufacturers are evaluating near-shoring options or investing in additional domestic capabilities to mitigate tariff risk and shorten lead times for critical components. These shifts carry implications for cost structures and unit economics, but they also offer potential resilience benefits that can be essential in maintaining clinical supply continuity.

Clinicians and hospital procurement teams are increasingly focused on total cost of care rather than unit price alone, factoring in device reliability, service coverage, and procedure throughput when selecting suppliers. Regulatory bodies and payers are watching these changes closely, as supply chain reconfiguration can affect device availability and continuity of care. Ultimately, stakeholders that proactively model tariff-driven scenarios, engage suppliers in collaborative cost-management, and communicate effectively with health systems will be better equipped to safeguard both margins and patient access as trade policy evolves.

Comprehensive segmentation insight revealing how product type, procedure approach, material selection, end user needs, and clinical indication intersect to shape commercial and clinical strategies

A nuanced segmentation view reveals where clinical demand, procedural choice, and material science converge to drive differentiated opportunities. When examining the market by product type, implantable cardioverter defibrillators present distinct subcategories including dual chamber, single chamber, and subcutaneous systems, each with unique clinical use cases and technology requirements. Left ventricular assist devices divide into durable and temporary solutions, reflecting divergent patient populations and service models. Pacemakers include biventricular, dual chamber, and single chamber devices, where pacing modality and programming complexity influence follow-up care and remote monitoring needs. Valve prostheses are split between bioprosthetic and mechanical options, with bioprosthetic valves further characterized by homograft and xenograft derivations, and mechanical valves differentiated by bileaflet and tilting disc designs, all of which carry implications for durability, anticoagulation management, and patient counseling.

Approach to procedure further stratifies adoption pathways: open heart surgery remains relevant where anatomical considerations or complex repair are necessary, with subvariants such as minimally invasive surgery and traditional sternotomy shaping hospital resource utilization. The transcatheter route, encompassing aortic and mitral valve replacement approaches, has expanded access to interventions for older or higher-risk patients and is driving investment in catheter design and imaging support. Material type continues to be a defining axis, with bioprosthetic options offering favorable hemodynamics and biological integration and mechanical choices providing long term durability; within these classes, distinctions such as homograft versus xenograft or bileaflet versus tilting disc inform both clinical selection and downstream management.

End user segmentation across ambulatory surgical centers, cardiac centers, and hospitals highlights diverse procurement preferences and service expectations, with ambulatory settings prioritizing efficiency and throughput while cardiac centers and hospitals emphasize comprehensive care pathways and complex case capabilities. Indication-level differentiation across aortic, mitral, pulmonary, and tricuspid lesions, and subcategories of regurgitation and stenosis for aortic and mitral pathologies, further refines clinical demand profiles, informing device form factors, delivery systems, and evidence generation priorities. Understanding these intersecting segmentation axes allows manufacturers and health systems to tailor product development, training, and commercial models to the specific needs of procedural approaches, material choices, and end user operational constraints.

A strategic assessment of how geographic differences across the Americas, Europe Middle East and Africa, and Asia Pacific shape clinical adoption, regulatory approach, and commercial strategy

Regional dynamics materially influence how cardiac prosthetic devices are developed, approved, adopted, and supported. In the Americas, a mature reimbursement environment and a high concentration of advanced cardiac centers create demand for innovative transcatheter solutions, integrated remote monitoring, and long-term device service programs. Clinical leaders in this region often drive evidence generation through comparative studies and registry participation, and commercial success typically hinges on strong clinical relationships and bundled care propositions.

The Europe, Middle East & Africa region presents a heterogeneous regulatory and reimbursement landscape where adoption patterns vary significantly between high-income Western European markets and other jurisdictions that may prioritize cost containment. In many European markets, centralized procurement frameworks and strong national registries support robust post-market surveillance, while reimbursement mechanisms and health technology assessment influence the speed of uptake for premium devices. Middle Eastern and African markets show selective demand driven by tertiary cardiac centers and inbound medical travel, creating niche opportunities for specialized products and service bundles.

Asia-Pacific combines rapidly expanding clinical capacity with large patient volumes and growing domestic manufacturing capabilities. Several markets in the region are investing heavily in minimally invasive and transcatheter programs, supported by local clinical training initiatives and partnerships. Pricing sensitivity and diverse payer structures encourage scaled manufacturing and cost-effective device designs, while regulatory authorities in leading markets are streamlining pathways to encourage innovation. Across regions, companies that align clinical development, regulatory strategy, and go-to-market models to local system incentives and procurement norms will find the most durable routes to adoption.

Key competitive and operational insights into how device manufacturers are leveraging research, partnerships, and service models to secure leadership in cardiac prosthetic markets

Leading companies in the cardiac prosthetic arena are pursuing a mix of innovation, service expansion, and ecosystem partnerships to protect and extend competitive positions. R&D focus areas include next-generation valve leaflet technology, low-profile catheter systems, improved sensing algorithms for implantable rhythm management devices, and mechanical designs that simplify implantation or reduce device-related complications. Commercially, companies are investing in training centers, proctoring networks, and long-term service contracts that reinforce clinical loyalty and generate steady aftermarket revenue.

Mergers and acquisitions continue to be a strategic lever, enabling rapid access to complementary technologies, manufacturing capacity, and regional footprints. Strategic alliances with imaging companies, digital health firms, and clinical networks are becoming more frequent as device makers seek to deliver integrated procedural solutions rather than stand-alone implants. At the same time, new entrants and specialized suppliers are accelerating competition in components and delivery systems, compelling incumbents to sharpen differentiation through clinical evidence and provider support models.

Operational excellence in manufacturing and quality systems remains a non-negotiable competency, particularly as regulators and hospitals emphasize device traceability and post-market performance. Firms that align product roadmaps with durable service ecosystems, clear reimbursement strategies, and efficient global manufacturing will be best placed to convert R&D investment into sustained commercial returns.

Actionable and prioritized recommendations for device developers and health system leaders to build resilient supply chains, evidence programs, and payer aligned commercialization strategies

Industry leaders should prioritize a multidimensional approach that balances innovation with operational resilience and payer engagement. First, invest in clinical evidence programs that demonstrate meaningful improvements in patient outcomes and cost of care, using registries, comparative effectiveness studies, and real-world data to build compelling narratives for clinicians and payers. Second, strengthen supplier relationships and consider regional manufacturing or dual sourcing to hedge against trade policy volatility and protect procedural continuity in hospitals.

Third, align commercial models with how end users purchase and deploy devices: develop streamlined offerings for ambulatory surgical centers that emphasize procedural efficiency, while designing comprehensive training and service packages for cardiac centers and tertiary hospitals. Fourth, integrate digital capabilities into devices and patient management pathways to support remote follow-up, detect complications early, and provide quantifiable value to payers. Fifth, pursue targeted geographic expansion that pairs clinical training investments with regulatory and reimbursement navigation to accelerate uptake in priority markets.

Finally, adopt a proactive regulatory and payer engagement posture that anticipates policy changes and secures favorable coverage pathways. Companies that operationalize these recommendations-by connecting R&D priorities to reimbursement strategies and supply chain resilience-will reduce commercialization risk and build sustainable competitive advantage.

A clear explanation of the blended research approach combining clinician interviews, regulatory and clinical evidence review, and supply chain analysis to ensure robust actionable insights

This research synthesizes primary insights from expert interviews with cardiac surgeons, interventional cardiologists, procurement leaders, and device engineers, combined with a systematic review of regulatory filings, clinical trial registries, and peer reviewed clinical literature. Quantitative and qualitative inputs were triangulated to identify adoption drivers, clinical barriers, and operational constraints across product types and procedural approaches.

Supply chain and tariff analyses were constructed using supplier mapping, import-export trend reviews, and procurement case studies to assess vulnerability and mitigation pathways. Segmentation was developed by aligning product taxonomies with clinical indications, procedural approaches, and end user dynamics, ensuring that each axis was informed by clinician practice patterns and hospital operational realities. Quality control included cross-validation of interview themes, methodological transparency, and iterative review with technical experts to ensure the robustness of conclusions and recommendations.

This blended methodology enables a holistic view of how device design, clinical practice, regulatory regimes, and commercial systems interact, producing insights that are both actionable and grounded in current clinical and operational evidence.

A concluding synthesis emphasizing the urgency for coordinated clinical, regulatory, and operational strategies to convert innovation into sustained clinical adoption and market resilience

In conclusion, the cardiac prosthetic device landscape is at an inflection point where clinical innovation, procedural migration, material advancements, and commercial model evolution are converging to reshape patient care pathways. Organizations that synchronize product development with rigorous evidence generation, resilient manufacturing strategies, and payer engagement will capture the greatest value and sustain adoption across diverse clinical settings.

Tariff and trade dynamics add a new layer of operational complexity that amplifies the importance of supplier strategy, regional manufacturing decisions, and transparent communication with health system partners. At the same time, regionally tailored commercialization and clinically integrated service models offer clear routes to differentiation. The imperative for leaders is to act decisively: align R&D investment to proven clinical needs, fortify supply chains against policy shifts, and build the evidentiary and commercial scaffolding required to translate innovation into improved patient outcomes and durable market performance.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cardiac Prosthetic Devices Market, by Product Type

  • 8.1. Implantable Cardioverter Defibrillators
    • 8.1.1. Dual Chamber Defibrillators
    • 8.1.2. Single Chamber Defibrillators
    • 8.1.3. Subcutaneous Defibrillators
  • 8.2. Left Ventricular Assist Devices
    • 8.2.1. Durable Ventricular Assist Devices
    • 8.2.2. Temporary Ventricular Assist Devices
  • 8.3. Pacemakers
    • 8.3.1. Biventricular Pacemakers
    • 8.3.2. Dual Chamber Pacemakers
    • 8.3.3. Single Chamber Pacemakers
  • 8.4. Valve Prostheses
    • 8.4.1. Bioprosthetic Valves
    • 8.4.2. Mechanical Valves

9. Cardiac Prosthetic Devices Market, by Procedure Approach

  • 9.1. Open Heart Surgery
    • 9.1.1. Minimally Invasive Surgery
    • 9.1.2. Traditional Sternotomy
  • 9.2. Transcatheter
    • 9.2.1. Transcatheter Aortic Valve Replacement
    • 9.2.2. Transcatheter Mitral Valve Replacement

10. Cardiac Prosthetic Devices Market, by Material Type

  • 10.1. Bioprosthetic
    • 10.1.1. Homograft
    • 10.1.2. Xenograft
  • 10.2. Mechanical
    • 10.2.1. Bileaflet
    • 10.2.2. Tilting Disc

11. Cardiac Prosthetic Devices Market, by Indication

  • 11.1. Aortic
    • 11.1.1. Regurgitation
    • 11.1.2. Stenosis
  • 11.2. Mitral
    • 11.2.1. Regurgitation
    • 11.2.2. Stenosis
  • 11.3. Pulmonary
  • 11.4. Tricuspid

12. Cardiac Prosthetic Devices Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Cardiac Centers
  • 12.3. Hospitals

13. Cardiac Prosthetic Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Cardiac Prosthetic Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Cardiac Prosthetic Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Cardiac Prosthetic Devices Market

17. China Cardiac Prosthetic Devices Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. Artivion, Inc.
  • 18.7. AtriCure, Inc.
  • 18.8. Biotronik SE & Co KG
  • 18.9. Boston Scientific Corporation
  • 18.10. Braile Biomedica
  • 18.11. Colibri Heart Valve LLC
  • 18.12. Edwards Lifesciences Corporation
  • 18.13. Fortive Corporation
  • 18.14. Lepu Medical Technology(Beijing)Co.,Ltd.
  • 18.15. LivaNova, PLC
  • 18.16. Medtronic PLC
  • 18.17. Meril Life Sciences Pvt. Ltd.
  • 18.18. Microport Scientific Corporation
  • 18.19. SGS Societe Generale de Surveillance SA.
  • 18.20. Shree Pacetronix Ltd.
  • 18.21. Siemens Healthineers AG
  • 18.22. TZ Medical
  • 18.23. Venus MedTech HangZhou Inc.
  • 18.24. Vitatron Holding B.V.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE APPROACH, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES CARDIAC PROSTHETIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA CARDIAC PROSTHETIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DUAL CHAMBER DEFIBRILLATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DUAL CHAMBER DEFIBRILLATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DUAL CHAMBER DEFIBRILLATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SINGLE CHAMBER DEFIBRILLATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SINGLE CHAMBER DEFIBRILLATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SINGLE CHAMBER DEFIBRILLATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SUBCUTANEOUS DEFIBRILLATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SUBCUTANEOUS DEFIBRILLATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SUBCUTANEOUS DEFIBRILLATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DURABLE VENTRICULAR ASSIST DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DURABLE VENTRICULAR ASSIST DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DURABLE VENTRICULAR ASSIST DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TEMPORARY VENTRICULAR ASSIST DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TEMPORARY VENTRICULAR ASSIST DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TEMPORARY VENTRICULAR ASSIST DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIVENTRICULAR PACEMAKERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIVENTRICULAR PACEMAKERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIVENTRICULAR PACEMAKERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DUAL CHAMBER PACEMAKERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DUAL CHAMBER PACEMAKERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DUAL CHAMBER PACEMAKERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SINGLE CHAMBER PACEMAKERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SINGLE CHAMBER PACEMAKERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SINGLE CHAMBER PACEMAKERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL VALVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL VALVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL VALVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE APPROACH, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRADITIONAL STERNOTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRADITIONAL STERNOTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRADITIONAL STERNOTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER AORTIC VALVE REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER AORTIC VALVE REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER AORTIC VALVE REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER MITRAL VALVE REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER MITRAL VALVE REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER MITRAL VALVE REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY HOMOGRAFT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY HOMOGRAFT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY HOMOGRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY XENOGRAFT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY XENOGRAFT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY XENOGRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BILEAFLET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BILEAFLET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BILEAFLET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TILTING DISC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TILTING DISC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TILTING DISC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AORTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AORTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AORTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AORTIC, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY REGURGITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY REGURGITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY REGURGITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY STENOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY STENOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY STENOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MITRAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MITRAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MITRAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MITRAL, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY REGURGITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY REGURGITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY REGURGITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY STENOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY STENOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY STENOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PULMONARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PULMONARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PULMONARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRICUSPID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRICUSPID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRICUSPID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY CARDIAC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY CARDIAC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 132. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 133. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE APPROACH, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL, 2018-2032 (USD MILLION)
  • TABLE 141. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 142. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AORTIC, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MITRAL, 2018-2032 (USD MILLION)
  • TABLE 144. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE APPROACH, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AORTIC, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MITRAL, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE APPROACH, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AORTIC, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MITRAL, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE APPROACH, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AORTIC, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MITRAL, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE APPROACH, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AORTIC, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MITRAL, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE APPROACH, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC, 2018-2032 (USD MILLION)
  • TABLE 220. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL, 2018-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 222. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AORTIC, 2018-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MITRAL, 2018-2032 (USD MILLION)
  • TABLE 224. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE APPROACH, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, 2018-2032 (USD MILLION)
  • TABLE 233. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
  • TABLE 234. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC, 2018-2032 (USD MILLION)
  • TABLE 236. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL, 2018-2032 (USD MILLION)
  • TABLE 237. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 238. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AORTIC, 2018-2032 (USD MILLION)
  • TABLE 239. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MITRAL, 2018-2032 (USD MILLION)
  • TABLE 240. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 245. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, 2018-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE APPROACH, 2018-2032 (USD MILLION)
  • TABLE 248. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, 2018-2032 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC, 2018-2032 (USD MILLION)
  • TABLE 252. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL, 2018-2032 (USD MILLION)
  • TABLE 253. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 254. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AORTIC, 2018-2032 (USD MILLION)
  • TABLE 255. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MITRAL, 2018-2032 (USD MILLION)
  • TABLE 256. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 257. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 258. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 259. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 261. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 262. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 263. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, 2018-2032 (USD MILLION)
  • TABLE 264. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE APPROACH, 2018-2032 (USD MILLION)
  • TABLE 265. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, 2018-2032 (USD MILLION)
  • TABLE 266. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
  • TABLE 267. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC, 2018-2032 (USD MILLION)
  • TABLE 269. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL, 2018-2032 (USD MILLION)
  • TABLE 270. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 271. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AORTIC, 2018-2032 (USD MILLION)
  • TABLE 272. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MITRAL, 2018-2032 (USD MILLION)
  • TABLE 273. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 274. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 275. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 277. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 278. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 279. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, 2018-2032 (USD MILLION)
  • TABLE 280. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE APPROACH, 2018-2032 (USD MILLION)
  • TABLE 281. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, 2018-2032 (USD MILLION)
  • TABLE 282. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
  • TABLE 283. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 284. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC, 2018-2032 (USD MILLION)
  • TABLE 285. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL, 2018-2032 (USD MILLION)
  • TABLE 286. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 287. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AORTIC, 2018-2032 (USD MILLION)
  • TABLE 288. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MITRAL, 2018-2032 (USD MILLION)
  • TABLE 289. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 290. EUROPEAN UNION CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 291. EUROPEAN UNION CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 292. EUROPEAN UNION CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 293. EUROPEAN UNION CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 294. EUROPEAN UNION CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 295. EUROPEAN UNION CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, 2018-2032 (USD MILLION)
  • TABLE 296. EUROPEAN UNION CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE APPROACH, 2018-2032 (USD MILLION)
  • TABLE 297. EUROPEAN UNION CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, 2018-2032 (USD MILLION)
  • TABLE 298. EUROPEAN UNION CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
  • TABLE 299. EUROPEAN UNION CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 300. EUROPEAN UNION CARDIAC P